Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




New Options for Improving Blood Transfusions

By HospiMedica International staff writers
Posted on 25 Jul 2011
A new study describes a method to prolong the lifesaving power of donated red blood cells (RBCs), by modulating the release of adenosine-5'-triphosphate (ATP). More...


Researchers at Duke University Medical Center (Duke; Durham, NC, USA) conducted a prospective, controlled, mechanistic study to test the hypothesis that RBC storage impairs their ability to release ATP, and that impaired ATP release is injurious in vivo, in part through increasing RBC adhesion. The researchers used human and mouse blood in nude mouse transfusion recipients, performing in vitro and in vivo manipulation of ATP release, supplemental ATP, and antibodies to RBC and endothelial adhesion receptors, to probe the roles of released ATP and adhesion in responses to transfused RBCs.

The researchers found that ATP levels declined markedly within 14 days after blood collection, despite relatively stable levels of ATP within the red blood cells. Inhibiting ATP release promoted the adhesion of stored RBCs to endothelial cells in vitro and RBC sequestration in the lungs of transfused mice in vivo. Unlike transfusion of fresh human RBCs, stored RBC transfusion in mice decreased blood oxygenation and increased extravasation of RBCs into the lung's alveolar air spaces. Similar findings were seen with transfusion of fresh RBCs treated with the ATP release inhibitors glibenclamide and carbenoxolone. These results were prevented by either coinfusion of an ATP analog or pretransfusion incubation of the RBCs with an antibody against the erythrocyte adhesion receptor Landsteiner-Wiener (intercellular adhesion molecule-4). The study was published on July 14, 2011, in the journal Critical Care Medicine.

“We show that the export of ATP is important to prevent red blood cells from sticking to the inner lining of blood vessel walls,” said lead author Timothy McMahon, MD, PhD, an associate professor of medicine at Duke. “With the supply and demand balance for red blood cells very, very tight, it's important to find ways to optimize the benefit of transfusions and extend the shelf life of stored blood.”

ATP is a multifunctional nucleotide used in cells as a coenzyme, often called the "molecular unit of currency" of intracellular energy transfer. It is produced by photophosphorylation and cellular respiration, formed from inorganic phosphate and adenosine diphosphate (ADP) or adenosine monophosphate (AMP), and contains three phosphate groups. ATP transports chemical energy within cells for metabolism and is used by enzymes and structural proteins in many cellular processes, including biosynthetic reactions, motility, and cell division.

Related Links:

Duke University Medical Center




Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.